Advertisement
Advertisement
U.S. Markets close in 4 hrs 36 mins
Advertisement
Advertisement
Advertisement
Advertisement

TherapeuticsMD, Inc. (TXMD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
9.97+0.02 (+0.15%)
As of 11:24AM EDT. Market open.
Advertisement

TherapeuticsMD, Inc.

951 Yamato Road
Suite 220
Boca Raton, FL 33431
United States
561 961 1900
https://www.therapeuticsmd.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees416

Key Executives

NameTitlePayExercisedYear Born
Mr. Robert G. FinizioCo-Founder1.22MN/A1971
Dr. Brian A. BernickCo-Founder & Chief Scientific Officer96.61kN/A1968
Mr. John C. K. Milligan IVChief Exec. Officer of VitaCare Prescription Services796.28kN/A1962
Mr. Hugh O'Dowd M.B.A.Pres, CEO & DirectorN/AN/A1966
Mr. Michael DoneganInterim CFO, Chief Accounting Officer and Principal Financial & Accounting OfficerN/AN/A1968
Mr. Marlan D. WalkerGen. CounselN/AN/A1976
Mr. Mitchell L. KrassanExec. VP and Chief Strategy & Performance OfficerN/AN/A1966
Ms. Julia M. AmadioChief Product OfficerN/AN/AN/A
Dr. Sebastian MirkinChief Medical OfficerN/AN/A1973
Mr. Bharat WarrierChief Manufacturing OfficerN/AN/A1979
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; TX-007HR and TX-008HR, which are transdermal patch product candidates; and TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Corporate Governance

TherapeuticsMD, Inc.’s ISS Governance QualityScore as of May 1, 2022 is 5. The pillar scores are Audit: 3; Board: 5; Shareholder Rights: 2; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement